A Pharmacological Approach to Degenerative Alterations of Arterial Walls

  • A. Simon
  • J. Levenson
  • M. Safar

Abstract

The pharmacological approach to the arterial system in man has received little attention until recently. The lack of investigation of arteries is due in part to the pulsatility of the physiological phenomena which take place on the arterial side of the circulation. Additionally, the study of arteries has been impaired for a long time by the absence of appropriate quantitative methods. Today, two important factors allow us to reevaluate the place of the arterial system in clinical and pharmacological investigations: (a) rapid developments in the field of cardiovascular pharmacology and (b) progress in non-invasive techniques. Hypertension, which produces degenerative changes in the whole circulatory system, represents a good model for investigation of the arteries and their response to pharmacotherapy.

Keywords

Angiotensin Propranolol Nifedipine Captopril Enalapril 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Benetos AM, Simon ACh, Bouthier JD, Levenson JA, Lagneau PL, Safar ME (1986) Pulse doppler: an evaluation of diameter, blood velocity and blood flow of the common carotid artery in patients with isolated unilateral stenosis of the internal carotid artery. Stroke 16:969–972CrossRefGoogle Scholar
  2. 2.
    Collis MG, Keddie JR (1981) Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin dependent and independent mechanism. Clin Sci 61:281–286PubMedGoogle Scholar
  3. 3.
    Cohen ML, Kurz KD (1982) Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK 421. J Pharmacol Exper Ther 220:63–69Google Scholar
  4. 4.
    Cox RH (1978) Passive mechanics and connective tissue compositions of canine arteries. Am J Physiol 234:H533–H541PubMedGoogle Scholar
  5. 5.
    Dobrin PB, Rovich AA (1969) Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries. Am J Physiol 217:1644–1652PubMedGoogle Scholar
  6. 6.
    Dobrin PB (1978) Mechanical properties of arteries. Physiol Rev 58:397–460PubMedGoogle Scholar
  7. 7.
    Drayer JL, Weber MA (1982) Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment. Am Heart J 104:660–664PubMedCrossRefGoogle Scholar
  8. 8.
    Flain SF, Zelis R (1981) The effects of nitroglycerin on regional blood flow during exercise in heart failure. In: Vanhoulec PM, Leusen I (eds) Vasodilatation. Raven Press, New York, pp 469–475Google Scholar
  9. 9.
    Fleckenstein A (1977) Specific pharmacology of calcium in myocardium: cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17:149CrossRefGoogle Scholar
  10. 10.
    Folkow B, Neil E (1971) Circulation. Oxford University Press, New York, pp 36–56Google Scholar
  11. 11.
    Folkow B (1982) Physiological aspects of primary hypertension. Physiol Rev 62:347–504PubMedGoogle Scholar
  12. 12.
    Folkow B (1983) Structural factors: the vascular wall consequences of treatment. Hypertension 5 [Suppl III]:58–62Google Scholar
  13. 13.
    Freis ED (1982) The Veterans’ trial and sequelae. Br J Clin Pharmacol 13:67–72PubMedGoogle Scholar
  14. 14.
    Furchgott RF, Davidson D, Lin CI (1979) Conditions which determine whether muscarinic agonists contract or relax rabbit aortic strips. Blood Vessels 16:213–214Google Scholar
  15. 15.
    Gent AN (1972) Fracture of elastomers. In: Liebowitz H (ed) Fracture. Academic Press, New YorkGoogle Scholar
  16. 16.
    Greenfield JC (1966) Pressure gradient technique. Rushmer RF (ed), Yearbook Medical Publishers, Chicago, pp 83–93Google Scholar
  17. 17.
    Gribbin B, Pickering IG, Sleight P (1979) Arterial distensibility in normal and hypertensive men. Clin Sci 56:413–417PubMedGoogle Scholar
  18. 18.
    Hallock P, Benson IC (1937) Studies on the elastic properties of human isolated aorta. J Clin Invest 16:595–602PubMedCrossRefGoogle Scholar
  19. 19.
    Ibsen H, Egan B, Osterziel K, Vander H, Julius S (1983) Reflex hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK 421 in normal humans. Hypertension 5:184–191Google Scholar
  20. 20.
    Korteweg DJ (1878) Über die Fortpflanzungsgeschwindigkeit des Schalles in elastischen Röhren. Ann Phys Chem Neue Foige 5:225Google Scholar
  21. 21.
    Levenson JA, Chelly J, Payen D, Simon ACh, Safar ME (1981) Vasodilating antihypertensive drugs: effect on arterial compliance. A preliminary report. Symposium sur les alpha-bloquants, pharmacologie expérimentale et clinique. Editions Masson pp 271–276Google Scholar
  22. 22.
    Levenson JA, Simon ACh, Bouthier JD, Benetos AM, Safar ME (1984) Post-synaptic alpha-blockade and brachial artery compliance in essential hypertension. J Hypertens 2:37–41PubMedCrossRefGoogle Scholar
  23. 23.
    Levenson JA, Simon ACh, Fiessinger JN, Safar ME, London GM, Housset EM (1982) Systemic arterial compliance in patients with arteriosclerotis obliterans of the lower limbs. Observations on the effect of intravenous propranolol. Arteriosclerosis 2:266–271PubMedCrossRefGoogle Scholar
  24. 24.
    Levenson JA, Simon ACh, Maarek BC et al. (1983) Comparative effects of beta-adrenergic blockade in systolic hypertension according to age. Eur Heart J 4 [Suppl G]: 51–54PubMedGoogle Scholar
  25. 25.
    Levenson J, Simon A, Safar M, Bouthier J, London G (1985) Elevation of brachial arterial blood velocity and volumic flow mediated by peripheral beta adreno- receptors in patients with borderline hypertension. Circulation 71(4):663PubMedCrossRefGoogle Scholar
  26. 26.
    Levenson JA, Safar ME, Simon ACh, Bouthier JD, Griener JL (1983) Systemic and arterial hemodynamic effects of nifedipine (20 mg) in mild to moderate hypertension. Hypertension 5 [Suppl V]:V57-V60PubMedGoogle Scholar
  27. 27.
    Levenson JA, Simon ACh, Bouthier JD, Maarek BC, Safar ME (1985) The effect of acute and chronic nicardipine therapy on forearm arterial hemodynamics in essential hypertension. Br J Clin Pharmacol 20:107s–113sPubMedGoogle Scholar
  28. 28.
    Levenson JA, Simon ACh, Safar ME, Bouthier JD, Maarek BC (1984) Large arteries in hypertension: acute effect of a new calcium entry blocker nitrendipine. J Cardiovasc Pharmacol 6[Suppl 7]: 1006–1010Google Scholar
  29. 29.
    Levenson JA, Simon ACh, Safar ME, Fiessinger JN, Housset EM (1982) Systolic hypertension in arteriosclerosis obliterans of the lower limbs. Clin Exp Hypertens [A] 4:1059–1072Google Scholar
  30. 30.
    Levenson JA, Simon ACh, Safar ME, Chelly JE, Gitelman RCh (1980) Effect of intravenous nitroglycerin on arterial compliance and baroreflex sensitivity in hypertension. In: Sleight PS (ed) Arterial baroreceptors and hypertension. Oxford University Press, Oxford, pp 510–520Google Scholar
  31. 31.
    Levenson JA, Simon ACh, Safar ME (1985) Vasodilatation of small and large arteries in hypertension. J Cardiovasc Pharmacol 7 [Suppl 2]: 115–120CrossRefGoogle Scholar
  32. 32.
    Maarek B, Simon AC, Levenson J, Bouthier J, Safar ME (1986) Chronic effects of pindolol on the arterioles, large arteries and veins of the forearm in mild to moderate essential hypertension. Clin Pharmacol Ther 39:403–408PubMedCrossRefGoogle Scholar
  33. 33.
    Leung DY, Glagov MS, Mathews MB (1976) Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 191:475–477PubMedCrossRefGoogle Scholar
  34. 34.
    McDonald DA (1974) Blood flow in arteries, 2nd edn. Edward Arnold, London, pp 309–350Google Scholar
  35. 35.
    Mason DT (1978) Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Am J Med 65:106PubMedCrossRefGoogle Scholar
  36. 36.
    Messerli FH, De Carvalho JGR, Christie B, Frohlich ED (1978) Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation 58:441PubMedGoogle Scholar
  37. 37.
    Milnor WR (1981) Steady flow and properties of the vascular wall. In: Milnor WR (ed) Hemodynamics. Williams and Wilkins, Baltimore, pp 11–48, 56–91Google Scholar
  38. 38.
    Noble MIM (1979) The load system-aortic input impedance and pressure gradient. In: Noble MIM (ed) The cardiac cycle. Blackwell Scientific Publications, Oxford, pp 163–192Google Scholar
  39. 39.
    Noordergraaf A (1978) Circulatory system dynamics. Academic Press, New York, pp 137–139Google Scholar
  40. 40.
    Nveten JM, Vanhoutte PM (1981) Calcium entry blockers and vasospasm. In: Vanhouette PM, Leusen I (eds) Vasodilatation. Raven Press, New York, pp459–468Google Scholar
  41. 41.
    Oates HF, Graham RM, Strokes GS (1977) Mechanism of the hypotensive action of prazosin. Arch Int Pharmacodyn Ther 227:41–48PubMedGoogle Scholar
  42. 42.
    O’Rourke MF (1982) Arterial function in health and disease. Churchill Livingstone, EdinburghGoogle Scholar
  43. 43.
    O’Rourke MF (1976) Pulsatile arterial hemodynamics in hypertension. Aust NZ J Med 6:40–48CrossRefGoogle Scholar
  44. 44.
    Packer M, Le Jemtel TH (1982) Physiologic and pharmacologic determinants of vasodilator response: a conceptual frame-work for rational drug therapy for chronic heart failure. Proc Cardiovasc Dis 24:275–292CrossRefGoogle Scholar
  45. 45.
    Roth AC, Young DF, Cholving R (1976) Effect of collateral and peripheral resistance on blood flow through arterial stenosis. J Biomed 9:367Google Scholar
  46. 46.
    Rushmer RK (1970) Cardiovascular dynamics. Saunders, Philadelphia, pp 163–167Google Scholar
  47. 47.
    Randall US, Elser MD, Bulloch GF et al. (1976) Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci 51:357–360Google Scholar
  48. 48.
    Safar ME, Simon ACh, Levenson JA, Cazor JL (1983) Hemodynamic effects of diltiazem in hypertension. Circ Res 52 [Suppl 1]: 169–173Google Scholar
  49. 49.
    Simon ACh, Levenson JA, Levy BY, Bouthier JE, Peronneau PA, Safar ME (1982) Effect of nitroglycerin on peripheral large arteries in hypertension. Br J Clin Pharmacol 14:241–246PubMedGoogle Scholar
  50. 50.
    Simon ACh, Levenson JA, Bouthie JD, Safar ME, Avolio AP (1985) Evidence of early degenerative changes or large arteries in human essential hypertension. Hypertension 7:675–680PubMedGoogle Scholar
  51. 51.
    Simon ACh, Safar ME, Levenson JA, Kheder AD, Levy BI (1979) Systolic hypertension: hemodynamic mechanisms and choice of antihypertensive treatment. Am J Cardiol 44:505–511PubMedCrossRefGoogle Scholar
  52. 52.
    Simon AC, Levenson JA, Bouthier JE, Safar ME (1984) Captopril induced changes in large arteries in essential hypertension. Am J Med 76:71–75PubMedCrossRefGoogle Scholar
  53. 53.
    Simon ACh, Levenson JA, Bouthier J, Maarek B, Safar ME (1985): Effects of acute and chronic angiotensinconverting enzyme inhibition on large arteries in human hypertension. J Cardiovasc Pharmacol 7[Suppl I]:45–51CrossRefGoogle Scholar
  54. 54.
    Simon ACh, Safar ME, Levenson JA, London GM, Levy BI, Chau NP (1979) An evaluation of large arteries compliance in man. Am J Physiol 237:H550-H554PubMedGoogle Scholar
  55. 55.
    Simon ACh, Safar ME, Levenson JA, Bouthier JD, Benetos AM (1983) Action of vasodilating drugs on small and large arteries of hypertensive patients. J Cardiovasc Pharmacol 5:626–631PubMedCrossRefGoogle Scholar
  56. 56.
    Simon ACh, Levenson JA, Bouthier JD et al. (1984) Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. Am J Cardiol 53:781–787PubMedCrossRefGoogle Scholar
  57. 57.
    Simon ACh, Levenson JA, Safar AM, Bouthier JD, Safar ME (1984) ACE inhibition and brachial artery haemodynamics in hypertension. Br J Clin Pharmacol 18:243s-246sPubMedGoogle Scholar
  58. 58.
    Simon ACh, Laurent S, Levenson JA, Bouthier JE, Safar ME (1983) Estimation of forearm arterial compliance in normal and hypertensive men from simultaneous pressure and flow measurements in the brachial artery, using a pulsed Doppler device and a first-order arterial model during diastole. Cardiovasc Res 17:331PubMedCrossRefGoogle Scholar
  59. 59.
    Smith JJ, Kampire JP (1980) Blood and the circulation: general features. In: Smith JJ, Kampire JP (eds) Circulatory physiology - the essentials. Williams and Wilkins, Baltimore, pp 1–18Google Scholar
  60. 60.
    Ulrych M, Frohlich ED, Dustan HP, Page IH (1968) Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation 37:411–416PubMedGoogle Scholar
  61. 61.
    Wallace JM, Stead EA (1959) Fall in pressure in radial artery during reactive hyperemia. Circ Res 7:876–879PubMedGoogle Scholar
  62. 62.
    Winbury MM (1982) Proximal and distal coronary arteries. In: Santamore WP, Bove AA (eds) Coronary artery disease. Urban and Schwarzenberg, Baltimore, pp 63–78Google Scholar
  63. 63.
    Wolinsky H (1980) Response of the rat aortic media to hypertension. Morphological and chemical studies. Circ Res 26:507Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • A. Simon
  • J. Levenson
  • M. Safar

There are no affiliations available

Personalised recommendations